01 3AbbVie Corporation
02 4Allergan Inc.
Patent Expiration Date : 2013-09-09
Date Granted : 2003-11-11
Brand Name : LUMIGAN RC
Patent Number : 2144967
Filing Date : 1993-09-09
Strength per Unit : 0.03%
Dosage Form : Ophthalmic Solution
Human Or VET : Human
Route of Administration : Topical Ophthalmic
Patent Expiration Date : 2013-09-09
Date Granted : 2003-11-11
Patent Expiration Date : 2013-09-09
Date Granted : 2003-11-11
Brand Name : LUMIGAN RC
Patent Number : 2144967
Filing Date : 1993-09-09
Strength per Unit : 0.01%
Dosage Form : Ophthalmic Solution
Human Or VET : Human
Route of Administration : Topical Ophthalmic
Patent Expiration Date : 2013-09-09
Date Granted : 2003-11-11
Patent Expiration Date : 2026-03-14
Date Granted : 2009-05-19
Brand Name : LUMIGAN RC
Patent Number : 2585691
Filing Date : 2006-03-14
Strength per Unit : 0.01%
Dosage Form : Ophthalmic Solution
Human Or VET : Human
Route of Administration : Topical Ophthalmic
Patent Expiration Date : 2026-03-14
Date Granted : 2009-05-19
Patent Expiration Date : 2023-02-03
Date Granted : 2012-07-03
Brand Name : LATISSE
Patent Number : 2475106
Filing Date : 2003-02-03
Strength per Unit : 0.03%
Dosage Form : Sterile Solution
Human Or VET : Human
Route of Administration : Topical
Patent Expiration Date : 2023-02-03
Date Granted : 2012-07-03
Patent Expiration Date : 2021-03-30
Date Granted : 2007-05-29
Brand Name : LATISSE
Patent Number : 2401731
Filing Date : 2001-03-30
Strength per Unit : 0.03%
Dosage Form : Sterile Solution
Human Or VET : Human
Route of Administration : Topical
Patent Expiration Date : 2021-03-30
Date Granted : 2007-05-29
Patent Expiration Date : 2013-09-09
Date Granted : 2003-11-11
Brand Name : LATISSE
Patent Number : 2144967
Filing Date : 1993-09-09
Strength per Unit : 0.03%
Dosage Form : Sterile Solution
Human Or VET : Human
Route of Administration : Topical
Patent Expiration Date : 2013-09-09
Date Granted : 2003-11-11
Patent Expiration Date : 2013-09-09
Date Granted : 2003-11-11
Brand Name : LUMIGAN PF
Patent Number : 2144967
Filing Date : 1993-09-09
Strength per Unit : 0.03% w / v
Dosage Form : Ophthalmic Solution
Human Or VET : Human
Route of Administration : Topical Ophthalmic
Patent Expiration Date : 2013-09-09
Date Granted : 2003-11-11
LOOKING FOR A SUPPLIER?
